NASDAQ : AKYA

Akoya Biosciences, Inc.

$1.29 USD

-$0.07 (-5.15%)

Volume
715.25K
Average Volume
582.12K
Market Capitalization
$64.44M
P/E Ratio
-1.15
Dividend Yield
0.00%
Price Target
$6.00
Year High
$3.42
Year Low
$0.93
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.61
Source Headline

Get AKYA Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

AKYA Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$6.24

8 analysts

AKYA Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2025-05-19 Canaccord Genuity Maintain Hold Hold
2025-04-29 Canaccord Genuity Maintain Hold Hold
2025-04-14 Piper Sandler Maintain Neutral Neutral
2025-03-25 Stephens & Co. Downgrade Overweight Equal Weight
2025-03-18 Stephens & Co. Maintain Overweight Overweight
2024-11-19 Piper Sandler Maintain Overweight Overweight
2024-11-15 Craig-Hallum Downgrade Buy Hold
2024-11-15 Canaccord Genuity Maintain Buy Buy
2024-08-13 Piper Sandler Maintain Overweight Overweight
2024-08-06 Morgan Stanley Downgrade Overweight Equal Weight
2024-08-06 BTIG Downgrade Buy Neutral
2024-08-06 Craig-Hallum Maintain Buy Buy
2024-08-06 JP Morgan Downgrade Overweight Neutral
2024-06-03 Morgan Stanley Maintain Overweight Overweight
2024-05-14 BTIG Maintain Buy Buy
2024-05-14 Canaccord Genuity Maintain Buy Buy
2024-03-06 JP Morgan Maintain Overweight Overweight
2024-03-05 Canaccord Genuity Maintain Buy Buy
2024-03-05 UBS Maintain Buy Buy
2023-11-13 Piper Sandler Maintain Overweight Overweight
2023-11-13 Stephens & Co. Maintain Overweight Overweight
2023-10-24 Morgan Stanley Maintain Overweight Overweight
2023-10-16 Piper Sandler Maintain Overweight Overweight
2023-10-12 UBS Maintain Buy Buy
2023-08-08 Stephens & Co. Maintain Overweight Overweight
2023-08-08 Morgan Stanley Maintain Overweight Overweight
2023-05-10 Morgan Stanley Maintain Overweight Overweight
2023-03-21 Stephens & Co. Maintain Overweight Overweight
2023-03-08 Morgan Stanley Maintain Overweight Overweight
2022-11-03 Capital One Maintain Overweight Overweight
2022-10-06 Stephens & Co. Maintain Overweight Overweight
2022-08-17 Piper Sandler Maintain Overweight Overweight
2022-06-22 BTIG Maintain Buy Buy
2022-05-16 Piper Sandler Maintain Overweight Overweight
2022-05-09 Morgan Stanley Maintain Overweight Overweight
2022-03-18 Piper Sandler Maintain Overweight Overweight
2022-03-15 Morgan Stanley Maintain Overweight Overweight
2022-02-15 Morgan Stanley Maintain Overweight Overweight
2021-05-11 Canaccord Genuity Maintain Buy Buy
2021-05-11 Piper Sandler Maintain Overweight Overweight
2021-05-11 JP Morgan Maintain Overweight Overweight
2021-05-11 Morgan Stanley Maintain Overweight Overweight